Pharmaceutical market in Romania will be largely impacted by the...
Romania’s pharmaceutical sales in the 12 months ending June 2012 increased by 13.6% y/y (16.9% y/y in local currency) to EUR 2.6bn (RON 11.5bn), backed by the good performance in the period Jul 2011 –...
View ArticlePharmaceutical industry in Singapore recuperating fast after Q2FY11′s ill spell
Singapore’s economy saw a period of subdued growth in last three quarters due to slowdown in exports growth. However, Singaporean pharmaceutical industry continued its V-shaped recovery in year 2012 as...
View ArticleNew pharmaceutical legislation causes ill effect in Poland
The Polish pharmaceutical market value (in gross retail prices) rose by 3.7% y/y to around PLN 22.3bn (EUR 5.4bn) in 2011. However, medicine sales declined this year due to the new controversial...
View ArticleRomanian pharmaceutical market falling sick?
Pharmaceutical sales increased by 5.2% y/y to RON 2.9bn (EUR 637.7mn) in Q3/2012, decelerating from the 12.6% y/y advance in H1. When expressed in EUR however, the market actually shrank by 0.9% y/y as...
View ArticleSingapore named best healthcare system in the Asian regions
SG Healthcare provides an overview of the healthcare industry in Singapore and the Asia Pacific. Singapore’s healthcare system is internationally recognized and was ranked 6th out of 191 countries and...
View ArticleRomania pharmaceutical market expected to grow in 2013
The Romanian pharmaceutical market growth eased to 8.3% y/y in 2012, from 12.4% y/y in 2011 and 18.8% y/y in 2010. The growth rates are expressed in RON and the consumer price inflation was 3.3% in...
View ArticlePharmaceutical industry in Singapore sees rapid growth
Over the last decade, Singapore has established itself as the manufacturing hub for leading pharmaceutical companies in Asia. The country’s manufacturing output of pharmaceuticals and biological...
View ArticleIs Romania’s pharmaceutical worry an epidemic or pandemic?
Romania’s pharmaceutical market distribution prices increased by 3.6% y/y to EUR 691.9mn in Q1/2013. The market edged up a mere 0.6% q/q in the quarter following difficulties stemming from regulatory...
View Article
More Pages to Explore .....